patients home  product info safety prescribing information elan pain information center prialt.com Search     Go Advanced Search Look In: All Product Information Literature      Keywords:    Select a category and enter values in the fields to limit your search. You can further refine your search by using the wildcard character (*) and Boolean operators (AND, OR). For detailed instructions on using Search, click Help SearchResetHelp

	Important Safety Considerations Warning: Severe psychiatric symptoms and neurological impairment may occur during treatment with PRIALT. Patients with a pre-existing history of psychosis should not be treated with PRIALT. All patients should be monitored frequently for evidence of cognitive impairment, hallucinations, or changes in mood or consciousness. PRIALT therapy can be interrupted or discontinued abruptly without evidence of withdrawal effects in the event of serious neurological or psychiatric signs or symptoms.

	PRIALT is for use only in the Medtronic SynchroMed® EL, SynchroMed® II Infusion System and the CADD-Micro ambulatory infusion pump. This website is intended for residents of the United States, Puerto Rico, and US Territories. PRIALT® is a registered trademark and is a trademark of Elan Pharmaceuticals, Inc. SynchroMed® is a registered trademark of Medtronic, Inc.